Cargando…

Novel treatments for complications after bariatric surgery

Bariatric surgery has been considered one of best treatments for obesity. As every surgical procedure—and any medical intervention, it is not exempt of complications, among which leaks, strictures, acute hemorrhages and fistulae highlight. Leaks are more common in the gastro-jejunal anastomosis (GJA...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández, Julián, Boza, Camilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791794/
https://www.ncbi.nlm.nih.gov/pubmed/26981148
http://dx.doi.org/10.1186/s13022-015-0021-2
_version_ 1782421140323434496
author Hernández, Julián
Boza, Camilo
author_facet Hernández, Julián
Boza, Camilo
author_sort Hernández, Julián
collection PubMed
description Bariatric surgery has been considered one of best treatments for obesity. As every surgical procedure—and any medical intervention, it is not exempt of complications, among which leaks, strictures, acute hemorrhages and fistulae highlight. Leaks are more common in the gastro-jejunal anastomosis (GJA) in the case of Roux-en-y Gastric Bypass (RYGB), while in Sleeve Gastrectomy (LSG) they locate in the stapler line. Stenosis can be seen in the gastro-jejunostomy in the RYGB and in the gastric tube in case of the LSG. For each of these complications, many innovative solutions have been developed, including new surgical devices. In spite of promising good results, evidence regarding utility and safeness of these technologies is still scarce. Self-expandable endoscopic stents have been used to treat leaks, with an overall success rate of 80–90 % and a migration rate of 15–35 %. The bear trap-like over-the-scope (Ovesco) clips have been used to treat GI hemorrhages, leaks and even fistulae, with a 70–80 % success rate, although more endoscopic sessions may be needed. Overstitch, an endosurgical suture devices, have been used to treat leaks, fistulae and perforations. Overall, technical success achievement approaches to 90 %, while clinical success ranges from 80 to 90 %, except for leaks closure, where a lower success rate has been observed. Despite of all of these advances, early diagnosis and treatment remains the main strategy to achieve success. In summary, novel therapies for complication management can be very useful, though further studies with larger series are still needed in order to confirm their efficacy and safeness.
format Online
Article
Text
id pubmed-4791794
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47917942016-03-16 Novel treatments for complications after bariatric surgery Hernández, Julián Boza, Camilo Ann Surg Innov Res Review Bariatric surgery has been considered one of best treatments for obesity. As every surgical procedure—and any medical intervention, it is not exempt of complications, among which leaks, strictures, acute hemorrhages and fistulae highlight. Leaks are more common in the gastro-jejunal anastomosis (GJA) in the case of Roux-en-y Gastric Bypass (RYGB), while in Sleeve Gastrectomy (LSG) they locate in the stapler line. Stenosis can be seen in the gastro-jejunostomy in the RYGB and in the gastric tube in case of the LSG. For each of these complications, many innovative solutions have been developed, including new surgical devices. In spite of promising good results, evidence regarding utility and safeness of these technologies is still scarce. Self-expandable endoscopic stents have been used to treat leaks, with an overall success rate of 80–90 % and a migration rate of 15–35 %. The bear trap-like over-the-scope (Ovesco) clips have been used to treat GI hemorrhages, leaks and even fistulae, with a 70–80 % success rate, although more endoscopic sessions may be needed. Overstitch, an endosurgical suture devices, have been used to treat leaks, fistulae and perforations. Overall, technical success achievement approaches to 90 %, while clinical success ranges from 80 to 90 %, except for leaks closure, where a lower success rate has been observed. Despite of all of these advances, early diagnosis and treatment remains the main strategy to achieve success. In summary, novel therapies for complication management can be very useful, though further studies with larger series are still needed in order to confirm their efficacy and safeness. BioMed Central 2016-03-15 /pmc/articles/PMC4791794/ /pubmed/26981148 http://dx.doi.org/10.1186/s13022-015-0021-2 Text en © Hernández and Boza. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Hernández, Julián
Boza, Camilo
Novel treatments for complications after bariatric surgery
title Novel treatments for complications after bariatric surgery
title_full Novel treatments for complications after bariatric surgery
title_fullStr Novel treatments for complications after bariatric surgery
title_full_unstemmed Novel treatments for complications after bariatric surgery
title_short Novel treatments for complications after bariatric surgery
title_sort novel treatments for complications after bariatric surgery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791794/
https://www.ncbi.nlm.nih.gov/pubmed/26981148
http://dx.doi.org/10.1186/s13022-015-0021-2
work_keys_str_mv AT hernandezjulian noveltreatmentsforcomplicationsafterbariatricsurgery
AT bozacamilo noveltreatmentsforcomplicationsafterbariatricsurgery